An endothelin receptor antagonist ameliorates injuries of sinusoid lining cells in porcine liver transplantation - 08/09/11
Abstract |
Background: TAK-044 is an endothelin receptor antagonist. Whether the agent has protective effects on liver graft injuries from non–heart-beating donors is unknown.
Methods: In donor pigs, cardiac arrest was induced by stopping the respirator. Forty-five minutes after cessation of the respirator, the liver was flushed with University of Wisconsin (UW) solution, preserved for 8 hours at 4°C, and transplanted orthotopically. The pigs were divided into two groups: a control group and a drug-treated group in which TAK-044 was given in the UW solutions (10 mg/L) and was administered to recipients (10 mg/kg body weight).
Results: TAK-044 treatment significantly increased recipient survival rate. After reperfusion of the graft, portal venous pressure and 15-minute retention rate of indocyanine green were significantly reduced in the drug-treated group. Electron microscopic findings indicated that TAK-044 attenuated endothelial cell injuries.
Conclusion: TAK-044 treatment improves the viability of livers harvested from non–heart-beating donors. The main effect of the agent is protection of endothelial cells from ischemia/reperfusion injuries.
Le texte complet de cet article est disponible en PDF.Plan
This work was supported in part by a grant from the Scientific Research Fund of the Ministry of Education, Japan, and a grant from the Japan Society for the Promotion of Science (JSPS-RFTF96I00202). |
Vol 178 - N° 1
P. 64-68 - juillet 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?